Reactive oxygen species-responsive Pluronic F127 hyaluronic hydrogel for targeted doxorubicin delivery in glioblastoma and enhanced survival with radiotherapy
Key Points
Survival rates improved significantly with the combined treatment of doxorubicin and radiotherapy.
The use of pluronic F127 hydrogel enabled targeted doxorubicin delivery in glioblastoma models.
Assessment utilized reactive oxygen species responsiveness to enhance drug delivery effectiveness.
These findings highlight the potential to improve glioblastoma treatment strategies, though further validation is required.
Reactive oxygen species-responsive Pluronic F127 hyaluronic hydrogel for targeted doxorubicin delivery in glioblastoma and enhanced survival with radiotherapy | Synapse
Also Consider
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: